BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 392325)

  • 1. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
    Ilyin NV; Dexter LI; Bochman YaV
    Neoplasma; 1979; 26(4):423-7. PubMed ID: 392325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The reactivity of the regional lymph nodes and tumor stroma in cervix uteri cancer].
    Raĭchev I; Raĭchev S
    Akush Ginekol (Sofiia); 1993; 32(1):25-8. PubMed ID: 8172342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Rand RJ; Jenkins DM; Bulmer R
    Clin Exp Immunol; 1978 Jul; 33(1):159-65. PubMed ID: 309370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.
    Rand RJ; Jenkins DM; Bulmer R
    Clin Exp Immunol; 1977 Dec; 30(3):421-8. PubMed ID: 304787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of axillary lymph node cells in patients with breast cancer.
    Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
    J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of T gamma cells in the regional lymph nodes of patients with uterine cervical cancer].
    Hiramatsu K; Ueda G; Inoue M; Tanaka Y; Inoue Y; Saito J; Nishino T; Kurachi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):947-52. PubMed ID: 6223965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stages of development of immunologic response in the regional lymph nodes in invasive cancer of the uterine cervix.
    Kozlowski H; Hrabowska M
    Arch Geschwulstforsch; 1977; 47(6):550-60. PubMed ID: 607906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
    Gupta S; Cunningham-Rundles S
    J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
    Fedin IuV; Ermilova VD
    Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of lymphocyte subsets in regional lymph nodes in uterine cervical cancer and its immunological significance].
    Kinugasa M; Akahori T; Mochizuki M; Hasegawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):383-90. PubMed ID: 2066610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of T- and B-lymphocyte counts in guinea pigs].
    Shvartsman MIa; Kashkin AP
    Biull Eksp Biol Med; 1982 Sep; 94(9):85-7. PubMed ID: 6983374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface markers on lymphocytes leaving pig lymph nodes.
    Pabst R; Binns RM; Licence ST
    Immunology; 1985 Oct; 56(2):301-6. PubMed ID: 3876982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune evaluation of cervical cancer patients--alteration of peripheral lymphocyte subpopulations--(author's transl)].
    Ishiguro T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):719-24. PubMed ID: 6972426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
    Kharabadze MV; Tabagari DZ
    Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of cyclophosphane and degranol on the T- and B-lymphocyte populations in the lymph nodes when administered endolymphatically].
    Davydov VF; Kuzin VB
    Farmakol Toksikol; 1986; 49(2):31-5. PubMed ID: 3486778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.